<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="153106">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02001090</url>
  </required_header>
  <id_info>
    <org_study_id>REK nr 2013/1758</org_study_id>
    <nct_id>NCT02001090</nct_id>
  </id_info>
  <brief_title>Vascular Function on the First Day After Cardiac Surgery</brief_title>
  <official_title>Vascular Function on the First Day After Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <authority>Norway: Regional Ethics Commitee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study examines the flow mediated dilation (FMD) of the brachial artery before and after
      cardiac surgery. FMD is measured with ultrasound technique. Increased flow is achieved
      trough obstructing blood flow with a cuff around the forearm for five minutes. FMD is
      measured before surgery and on the first morning after the operation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>flow mediated dilation of the brachial artery</measure>
    <time_frame>one day</time_frame>
    <safety_issue>No</safety_issue>
    <description>Transitory change in FMD as a consequence of cardiac surgery with use of extra corporal circulation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reactive hyperemia</measure>
    <time_frame>one day</time_frame>
    <safety_issue>No</safety_issue>
    <description>Transitory change in reactive hyperemia after five minutes of occlusion of forearm blood flow as a consequence of cardiac surgery with the use of extra corporal circulation.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">25</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>CABG patients</arm_group_label>
    <description>Patients undergoing cardiac surgery for coronary artery disease with the use of heart-lung machine in St Olavs Hospital Trondheim University Hospital.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing coronary artery bypass surgery.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  admitted for coronary artery bypass surgery

        Exclusion Criteria:

          -  Ongoing treatment with nitrates or RAAS inhibiting drugs

          -  unstable coronary syndrome

          -  unstable circulation/shock

          -  renal failure

          -  hepatic failure

          -  autoimmune or inflammatory disease

          -  untreated hypertension.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Idar Kirkeby-Garstad, Md. PhD.</last_name>
    <role>Study Director</role>
    <affiliation>Department of Cardiothoracic Anesthesiolgy and Intensive Care, St. Olav's Hospital, Trondheim, Norway</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St. Olavs Hospital</name>
      <address>
        <city>Trondheim</city>
        <state>Sør Trøndelag</state>
        <zip>7006</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <lastchanged_date>June 2, 2014</lastchanged_date>
  <firstreceived_date>November 27, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiac Surgical Procedures</keyword>
  <keyword>Heart-Lung Machine</keyword>
  <keyword>Coronary Artery Bypass</keyword>
  <keyword>Brachial Artery</keyword>
  <keyword>Vasodilation</keyword>
  <keyword>Regional Blood Flow</keyword>
  <keyword>Ultrasonography</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
